Phase 1b study of the oral gemcitabine ‘Pro-drug’ LY2334737 in combination with capecitabine in patients with advanced solid tumors
Crossref DOI link: https://doi.org/10.1007/s10637-015-0207-9
Published Online: 2015-02-03
Published Print: 2015-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Infante, Jeffrey R.
Benhadji, Karim A.
Dy, Grace K.
Fetterly, Gerald
Ma, Wen Wee
Bendell, Johanna
Callies, Sophie
Adjei, Alex A.
Text and Data Mining valid from 2015-02-03
Version of Record valid from 2015-02-03
Article History
Received: 11 November 2014
Accepted: 8 January 2015
First Online: 3 February 2015